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Methylation of nuclear genes encoding mitochondrial proteins participates in the
regulation of mitochondria function. The existence of cytosine methylation in the
mitochondrial genome is debated. To investigate whether mitochondrial DNA (mtDNA)
is methylated, we used both targeted- and whole mitochondrial genome bisulfite
sequencing in cell lines and muscle tissue from mouse and human origin. While
unconverted cytosines were detected in some portion of the mitochondrial genome,
their abundance was inversely associated to the sequencing depth, indicating that
sequencing analysis can bias the estimation of mtDNA methylation levels. In intact
mtDNA, few cytosines remained 100% unconverted. However, removal of supercoiled
structures of mtDNA with the restriction enzyme BamHI prior to bisulfite sequencing
decreased cytosine unconversion rate to <1.5% at all the investigated regions: D-loop,
tRNA-F+12S, 16S, ND5 and CYTB, suggesting that mtDNA supercoiled structure
blocks the access to bisulfite conversion. Here, we identified an artifact of mtDNA
bisulfite sequencing that can lead to an overestimation of mtDNA methylation levels.
Our study supports that cytosine methylation is virtually absent in mtDNA.
Keywords: epigenetics, DNA methylation, mitochondria, bisulfite sequencing, whole genome bisulfite sequencing
INTRODUCTION
DNA methylation is a major epigenetic modification which participates in the regulation of gene
expression by controlling the access of the transcription machinery to promoters. Previously,
we and others have reported that the master regulator of mitochondrial function Peroxisome
Proliferator-Activated Receptor Gamma Coactivator 1-alpha (PPARGC1A) can be epigenetically
reprogrammed by dietary lipids (Staiger et al., 2005; Rönn et al., 2008; Barrès et al., 2009). While
investigating the possible contribution of mitochondrial DNA (mtDNA) methylation in the control
of mitochondrial function (and the potential role of dietary factors) would be of great interest, it
requires first to clarify on the contentious existence of DNA methylation in the mitochondrial
genome.
A seminal study done in mouse and hamster cells showed that mtDNA is readily methylated,
although at lower levels compared to nuclear DNA (Nass, 1973). Using assays for quantifying
methylation relying on methyl-sensitive restriction enzymes, several groups estimated, in both
human and murine cells, that 2–5% of cytosines are methylated in mtDNA (Shmookler Reis
and Goldstein, 1983; Pollack et al., 1984). Using methylated DNA immunoprecipitation (MeDIP)
to capture mtDNA enriched for 5-methylcytosine or 5-hydroxymethylcytosine followed by real
time PCR, apparent methylation of mtDNA was detected in cells from human buffy coat
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(leucocytes) as well as in different human and mouse cells lines
(HCT1116, HeLa, 143B.TK−, human fibroblast, MEFs, and 3T3-
L1) and piglets (Shock et al., 2011; Bellizzi et al., 2013; Jia et al.,
2013, 2015). Moreover, substantial levels of DNA methylation
were detected from purified mitochondrial fractions by both
ELISA and mass spectrometry (Infantino et al., 2011; Chen et al.,
2012; Dzitoyeva et al., 2012; Menga et al., 2017).
Another approach used to quantify DNA methylation is
bisulfite sequencing. This assay relies first on the chemical
conversion of unmethylated cytosines into uracils and then
thymines, whereas methylated cytosines remain intact. Using
bisulfite sequencing in human buffy coat cells, cord blood cells,
cancer cell lines, or placental tissue (Byun et al., 2013, 2016;
Janssen et al., 2015; Zheng et al., 2015; Bianchessi et al., 2016;
van der Wijst et al., 2017), as well as mouse liver, brain, or
testes (Wong et al., 2013), mtDNA methylation in the D-loop
region and in 12S or 16S genes was estimated in the range of
1–20%. Intriguingly, despite the plethora of studies reporting
methylation of cytosine exists in mtDNA, several studies using
bisulfite sequencing have challenged the presence of methylation
in mtDNA by reporting that mtDNA is either not methylated
(Dawid, 1974; Hong et al., 2013) or methylated at very low levels
(below 2%) (Liu et al., 2016).
In the present study, we aimed to use both targeted- and
genome wide bisulfite sequencing approaches to examine the
existence of cytosine methylation in mtDNA from mouse and
human cells. Our data reveal bisulfite sequencing analysis bias as
a possible source of overestimation of mtDNA methylation levels
and provides evidence that the secondary structure of mtDNA is
a potential source of false bisulfite sequencing positives.
MATERIALS AND METHODS
Cell Culture
Human ovarian cancer cells SKOV3 were a gift from Kristian
Helin’s lab (Copenhagen). Human embryonic kidney cells
HEK293 and SKOV3 cells were maintained in DMEM with 20%
FBS and 1% penicillin-streptomycin in an atmosphere of 5% CO2
at 37◦C.
Lonza human skeletal muscle myoblasts (Lonza) were
maintained in DMEM/F-12, GlutaMAXTM (Gibco, Life
Technologies) supplemented with 20% Fetal Bovine Serum (FBS,
Sigma-Aldrich) and 1% penicillin-streptomycin (Invitrogen) in
5% CO2 at 37◦C. At 70–80% confluency, differentiation was
induced by reducing the FBS concentration to 2%. Experiments
were conducted when cells were fully differentiated myotubes,
after 5–7 days in differentiation medium.
Animals
Wild type C57BL/6J male mice (Taconic Biosciences, Denmark)
were 6–8 weeks of age at delivery and single-housed for
acclimatization 1 week prior to the start of the experiment.
All experiments were conducted in accordance with national
Danish guidelines (amendment #1306 of November 23, 2007)
as approved by the Danish Animal Experiments Inspectorate
(#2014-15-2934-01,027). Mouse muscle tissues were collected
from donor mice of the previously published experiment (Jensen
et al., 2016).
Mitochondrial Isolation and mtDNA
Extraction
Mitochondria from human myotubes were isolated with an
adapted protocol described elsewhere (Mercer et al., 2011). Cells
were trypsinized with Trypsin-2.5% EDTA and resuspended in
PBS. Cells were resuspended in swelling buffer (10 mM NaCl,
1.5 mM MgCl2 and 10 mM Tris-HCl, pH 7.5 all from Sigma-
Aldrich) and were allowed to swell for 5 min on ice. Cells were
then homogenized seven times with a 7-ml glass homogenizer
and sucrose concentration was adjusted to 250 mM. Nuclei
were sedimented by centrifugation at 1300 g for 3 min at 4◦C.
The supernatant containing the mitochondria was transferred to
another tube and centrifuged at 15,000 g for 10 min at 4◦C. The
mitochondrial pellet was centrifuged for an additional 15 min at
15,000 g at 4◦C. The mitochondrial pellet was resuspended in
PBS and mtDNA was extracted using DNeasy Blood and Tissue
Kit (Qiagen) and quantified using Qubit dsDNA HS Kit (Life
Technologies).
Mitochondria from mouse gastrocnemius were isolated using
an adapted protocol described elsewhere (Lanza and Nair,
2009). The muscle was placed immediately into ice-cold muscle
homogenization buffer (100 mM KCl, 50 mM Tris-HCl, 5 mM
MgCl2, 1.8 mM ATP, and 1 mM EDTA pH 7.2, all from Sigma-
Aldrich). Fat and connective tissues were removed, and the
muscle was minced. Muscle pieces incubated for 2 min in
1 mL of protease medium [1 mL homogenization buffer and
5.66 mg protease from Bacillus licheniformis, 10.6 U/mg (Sigma-
Aldrich)], washed twice with 3 mL of homogenization buffer, and
transferred to a homogenizer containing 4 mL of homogenization
buffer. The muscle was homogenized using a motor-driven
homogenizer for 5 min at 150 rpm with slow vertical plunger
movements. The homogenate was then centrifuged at 900 g for
5 min at 4◦C. The supernatant containing the mitochondria was
collected, and centrifuged a first time at 900 g for 5 min 4◦C
and a second time at 10,000 g for 5 min at 4◦C to pellet the
mitochondria. The pellet was washed once with homogenization
buffer, and centrifuged for 5 min at 9,000 g at 4◦C. The
mitochondrial pellet was finally resuspended in PBS and mtDNA
was extracted using DNeasy Blood and Tissue Kit (Qiagen).
RNase A (Qiagen) treatment was included in the protocol.
Restriction Enzyme Treatment
Genomic DNA was either untreated or treated with BamHI
restriction enzyme (New England Biolabs, cat # R0136) to
obtain circular or linearized mtDNA. BamHI recognize and
cuts G/GATCC, which is found only at one site in the human
mitochondrial DNA at position 14258. The DNA was treated
for 4 h at 37◦C according to the recommendations from the
manufacturer.
Bisulfite Conversion and PCR
Genomic DNA was bisulfite converted using EZ DNA
methylation-lightning kit (Zymo Research, United States)
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according to the manufacturer’s instructions. The converted
DNA was amplified using bisulfite converted primers designed
using the online primer design programs BiSearch (Tusnády
et al., 2005; Arányi et al., 2006) or Methprimer (Li and Dahiya,
2002) (Table 1). Primers for the D-loop, tRNA-f+12S and
ND5 targeted the heavy strand, whereas primers for 16S and
CYTB targeted the light strand. Primers were checked for
specificity using BiSearch to ensure that only mtDNA was
amplified. mtDNA amplification was performed using the
HotStar Taq plus DNA polymerase kit (Qiagen) according
to the manufacturer’s instructions. Briefly, 100 ng converted
DNA, 500 µM sense and anti-sense primers and HotStar Taq
polymerase 7.5 units/reaction were mixed in a total volume of
50 µl. The PCR was run with the following conditions: 5 min
95◦C (60 s 94◦C; 60 s 53–55◦C; 60 s 72◦C) × 35 cycles; 10 min
72◦C. Primers were either used separately or multiplexed.
When multiplexing primers 200 ng converted DNA was used
and the following cycling conditions: 5 min 95◦C (60 s 94◦C;
90 s 53–55◦C; 90 s 72◦C) × 35 cycles; 10 min 72◦C. PCR
products were subjected to gel electrophoresis on 2% agarose
(Lonza) and extracted using QIAquick Gel Extraction Kit
(Qiagen).
Bisulfite Sequencing Library Preparation
Library preparation of bisulfite-converted PCR products
was performed using NEBNext Ultra DNA Library Kit for
Illumina (New England Biolabs) according to the manufacturer’s
instructions. In short, 100 ng of PCR product was end-
repaired and ligated to adaptors. During PCR amplification
indexes from NEBNext Singleplex Kit (New England Biolabs)
were introduced and libraries were purified using AMPure
beads (Beckman Coulter). Libraries were subjected to 150 bp
paired-end sequencing using an Illumina MiSeq instrument
(Illumina). Total number of reads was approximately 15
million.
Whole Mitochondrial Genome Bisulfite
Sequencing (WMGBS)
Mitochondria were isolated and mtDNA was purified as
described above. Whole mitochondrial genome bisulfite
sequencing (WMGBS) was performed using EpiGnomeTM
Methyl-Seq Kit (Epicentre, Illumina) according to the
manufacturer’s protocol. Mitochondrial DNA was sonicated
2 × 10 min 30 Hz using Bioruptor (Diagenode) and bisulfite
converted using EZ DNA Methylation-Lightning kit (Zymo
Research). 50 ng converted mtDNA was used for library
preparation. Random hexamers were added to converted
mtDNA following first strand synthesis. After the addition
of tag sequences to the 3′ and 5′ ends, a PCR was performed
to amplify libraries for 2nd strand synthesis and to add both
adaptor and indexes. Libraries were purified using AMPure
beads (Beckman coulter) and quality-controlled on a Bioanalyzer
2100 (Agilent Technologies). Libraries were subjected to 150 bp
paired-end sequencing using Illumina MiSeq instrument
(Illumina).
Bioinformatics
Whole mitochondrial genome reads and targeted regions
were processed similarly: reads were preprocessed with
Trim Galore v0.4.1 & Cutadapt v1.12 (Martin, 2011) with
the --paired and --trim1 flags set. Due to biases introduced
by the primers (visible in an M-bias plot, data not shown) the
first nucleotides of each read were trimmed, whole genome
reads had 10 nucleotides removed while reads from targeted
regions had 2 removed. Preprocessed reads were aligned
to the hg38 or mm10 genome depending on dataset using
Bismark v0.16.3 (Krueger and Andrews, 2011) assisted by
Bowtie2 v2.2.8 (Langmead and Salzberg, 2012) and with
the --dovetail flag set. Whole mitochondrial genome reads
were de-duplicated using the Bismark de-duplication module.
Reads mapping to the mitochondrial genome were extracted
using samtools v1.3.1 (Li et al., 2009). Finally, methylation
individual methylation levels were extracted using Bismark
methylation with the flags --cytosine_report and --CX_
context.
Further analysis and visualization was done in the R statistical
environment (R Development Core Team, 2014), using the
packages data.table (Anon, 2017) and ggplot2 (Wickham, 2009).
Testing for the effect of linearizing mtDNA was done using
a sign-test and adjusted by Bonferroni correction. Smoothed
TABLE 1 | mtDNA primer sequences used for targeted bisulfite sequencing.
Primer Sequence Location Amplicon size
D-Loop FWD: AAATCTATCACCCTATTAAC 6–298 292
RVSE: GTGGAAATTTTTTGTTATGATGT
D-Loop FWD: CATAACAAAAAATTTCCACCAAAC 279–458 179
RVSE: GGGAAAATAATGTGTTAGTT
tRNA-F/12S FWD: TTTATATAACTTACCTCCTC 577–765 188
RVSE: GTGTTTGATGTTTGTTTTTTTTG
16S FWD: AATAAATTTATAGGTTTTTAAATTATTAAAT 2763–2873 110
RVSE: TAACTAATAAAATCTTAACATATACTACTC
ND5 FWD: TTCAAATATCTACTCATCTTC 12687–12856 169
RVSE: ATAGGATTGTTTGAATGGTT
CYTB FWD: GGTATTATTTTTTTGTTTGTAATTATAGTA 15091–15243 152
RVSE: CCTCAAATTCATTAAACTAAATCTATCC
Frontiers in Genetics | www.frontiersin.org 3 November 2017 | Volume 8 | Article 166
fgene-08-00166 October 30, 2017 Time: 15:37 # 4
Mechta et al. Analysis of Cytosine Methylation in the Mitochondrial Genome
conditional means were calculated using the “gam” method and
a span of 0.2. All correlations calculated are Pearson correlations.
Statistical Analysis
Statistical analysis was performed using R statistical environment
software. In whole genome bisulfite sequencing correlations
between estimated methylation and sequencing depth were based
on the ∼6,000 to ∼12,000 mitochondrial cytosines covered by
the experiment with an estimated methylation greater than 0.
The Pearson correlation coefficient was calculated between the
logarithm of the number of reads covering a cytosine and the
logarithm of the estimated methylation. A P-value ≤ 0.05 was
considered statistically significant.
RESULTS
Detection of Mitochondrial DNA
Methylation Is Inversely Correlated with
Sequencing Depth
To map methylation patterns across the whole mitochondrial
genome at single base-pair resolution, we performed whole
mitochondrial genome bisulfite sequencing (WMGBS).
Methylation of mtDNA has been detected in mouse skeletal
muscle tissue (Wong et al., 2013) but not in human Epithelial
Kidney cells (HEK293) (Hong et al., 2013). Thus, we chose
mouse muscle tissue, human muscle and HEK293 cells to
study mtDNA methylation. While cytosine unconversion rate in
WMGBS was detected up to 100% at certain positions, suggesting
100% methylation at a few specific mtDNA sites, it was striking
to observe that cytosine unconversion rate was negatively
associated with sequencing depth: in human cell lines and in
mouse skeletal muscle, mtDNA methylation at specific cytosine
residues was higher when these residues had a low sequencing
coverage (Figure 1 and Supplementary Figures 1A–E). Indeed,
calculation of the Pearson correlation coefficient between
mtDNA methylation and sequencing depth returned a very
tight negative correlation (R = −0.907, P < 2.2E-16; Figure 2).
The fact that mtDNA from HEK293 cells had an overall higher
sequencing depth than other cells or tissues and was associated
to a lower detection of methylation levels, further supports
that sequencing depth can influence the estimation of mtDNA
methylation (Figure 1).
NUMTs Do Not Cause Overestimation of
mtDNA Methylation
Given the inevitable contamination of mtDNA preparation with
nuclear DNA (nDNA), nuclear insertions of the mitochondrial
genome, named NUclear MiTochondrial segments (NUMTs)
(Ramos et al., 2011), represent a potential source of analysis
bias after WMGBS. While short NUMTs and NUMTs with low
sequence similarity are easy to computationally distinguish from
mtDNA, longer NUMTs or NUMTs with sequence similarities
could influence the quantification of mtDNA methylation.
However, we found no correlation between methylation levels
and the length of NUMTs (R = 0.06, P = 0.11; Supplementary
FIGURE 2 | Correlation analysis between sequencing depth and cytosine
unconversion rate. WMGBS shows an inverse relationship between mtDNA
cytosine unconversion rate (Methylation %) and sequence depth (Number of
reads) in both human and mouse cells. Log log scales are shown in the upper
right corner. The correlation coefficient is R = –0.907, P < 2.2E-16 and
obtained by pooling all samples.
Figure 2A), and only a marginal correlation between methylation
and NUMT alignment score, a score established to represent
how well each NUMTs align to mtDNA (Ramos et al., 2011)
(R = −0.1, P = 0.006; Supplementary Figure 2B). Bisulfite
conversion reduces the sequence complexity of unmethylated
DNA and thus, distinguishing NUMTs from mtDNA could be
more difficult after bisulfite conversion. To ensure that we could
distinguish NUMTs in our analysis, we extracted all possible
300 bp reads from both methylated and unmethylated NUMTs
and aligned them back onto the genome using the same setting
as in the main analysis. Of the 900.000+ possible reads, none of
them aligned to the mitochondrial genome. These results indicate
that in our mtDNA preparations, contamination of nDNA was
not at the origin of the methylation signal.
The Secondary Structure of mtDNA as a
Source of Overestimation of Methylation
Levels
The difference in sequencing depth across the mtDNA that
we detected in our WMGBS analysis could originate from
the secondary structure of mtDNA. The mtDNA genome can
be organized in coiled and supercoiled secondary structures
(Kolesar et al., 2013). During sonication of mtDNA, a step
of the WGBS protocol, certain mtDNA fragments that are
less tightly engaged in the mtDNA supercoiled structure have,
in theory, the potential to be preferably freed and ligated to
sequencing adapters. This would result in an overrepresentation
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FIGURE 1 | Inverse relationship between methylation of mtDNA and sequencing depth. The number of reads and methylation percentage is shown in the
mitochondrial genome from position 1000–3000 on the sense strand. In red, human HEK293 cells; in green, human primary muscle cells; in blue, mouse skeletal
muscle. We analyzed all cytosines in each of the samples corresponding to 6,000–12,000 cytosines.
of mtDNA fragments that do not engage in supercoiling. We
tested the hypothesis that mtDNA supercoils can be a source of
overestimation of methylation by subjecting DNA to digestion
with the BamHI restriction enzyme prior to targeted bisulfite
sequencing to remove any secondary structure and linearize
mtDNA. We focused our analysis on five mitochondrial regions
near the origin of replication and transcription start site for
the heavy strand: the displacement Loop (D-Loop), tRNA
phenylalanine and 12S ribosome (tRNA-F+12S), 16S ribosome
(16S), NADH dehydrogenase 5 (ND5) and cytochrome b (CYTB)
mRNA-encoding gene (sequencing primers are shown in Table 1)
in two human cell lines; In human myotubes and the ovarian
cancer cell line SKOV3. mtDNA methylation has previously been
detected in SKOV3 cells (van der Wijst et al., 2017). In the
D-loop (position 6–298), we found methylation levels from 0–
4.8% in Lonza and 0–16.9% in SKOV3 cells with undigested
mtDNA. In contrast, the same region after BamHI digestion
showed substantial lower methylation levels (0–0.6%, 0–1.1%
P = 2.02E-41, P = 1.40E-24). Similarly, in the position 279–458
of the D-loop, we detected 5.5–15.1% and 0.5–1% methylation
in undigested vs. digested mtDNA from Lonza, respectively,
(P = 5.00E-12) whereas for SKOV3 cells, we detected 19–32.3%
and 0.8–1.5% (P = 8.20E-08). In the regions encoding tRNA
phenylalanine and the 12S ribosomal RNA and 16S ribosomal
RNA, the methylation percentage dropped from 0–7.9% to
0–1.1% (P = 9.22E-15) and 0–0.9% to 0–0.6% (P = 6.50E-05)
in Lonza and 0–11.1% to 0–1.1% in SKOV3 cells (P = 1.30E-
9), respectively. Finally, in the ND5 and CYTB regions the drop
was from 0–3.8% to 0–1.3% (P = 1.7E-05) and 0–1.2% to 0–0.5%
(P = 2.95E-09) after digestion for LONZA and from 0–7.9% to
0–1.1% (P = 1.0E-12) and 0–1.8% to 0–0.8% (P = 6.68E-13)
for SKOV3 cells, respectively (Figure 3). These results suggest
that mtDNA secondary structure impairs bisulfite conversion
and infer that the secondary structure of mtDNA is a source of
overestimation of methylation levels in bisulfite sequencing.
DISCUSSION
Here, we used targeted- and whole mitochondrial genome
bisulfite sequencing to determine the methylation profile of
mtDNA. Our whole mitochondrial genome approach showed a
very tight correlation between sequencing depth and methylation
levels at specific cytosines, thereby revealing a potential bisulfite
sequencing artifact. Removal of the mtDNA secondary structure
by restriction enzyme digestion prior to sequencing dramatically
decreased cytosine unconversion rate. Our findings support that
cytosine methylation is absent in mtDNA and provide technical
insight into the possible source of overestimation of mtDNA
methylation levels.
Frontiers in Genetics | www.frontiersin.org 5 November 2017 | Volume 8 | Article 166
fgene-08-00166 October 30, 2017 Time: 15:37 # 6
Mechta et al. Analysis of Cytosine Methylation in the Mitochondrial Genome
FIGURE 3 | BamHI digestion prior to bisulfite sequencing decreases cytosine unconvertion rate. Targeted bisulfite sequencing was used to compare undigested and
digested DNA methylation levels at five different regions of the mtDNA from human muscle cells and SKOV3 cells (N = 3). (A) Drawing displays the mtDNA regions
investigated by targeted bisulfite sequencing. (B) Percentage methylation for undigested and digested mtDNA. Full circle represents cytosines in CpG context
whereas open circle is cytosines in non-CpG context. Results are presented with a min-max interval and a sign test was used to test for significant methylation
differences. D-loop (6–298) P = 2.02E-41 (Lonza) and P = 1.40E-24 (SKOV3); D-loop (279–458): P = 5.00E-12 (Lonza) and P = 8.20E-08 (SKOV3); tRNA-F+12S:
P = 9.22E-15 (Lonza) and P = 1.29E-9 (SKOV3); 16S: P = 6.50E-05; ND5: P = 1.70E-05 (Lonza) and P = 9.97E-13 (SKOV3); CYTB: P = 2.96E-09 (Lonza), and
P = 6.68E-13 (SKOV3). D-loop (6–298) includes origin of replication and tRNA-F+12S includes heavy strand promoter 2. PH1: heavy-strand promoter 1; PH2:
Heavy-strand promote 2; PL: Light-strand promoter; OH: Origin of replication from heavy-strand; OL: Origin of replication from light-strand. ND: not determined.
Our whole mitochondrial genome bisulfite sequencing
analysis showed that methylation levels were higher for sequences
with low coverage, but not with high sequencing depth. This
observation indicates that (1) some mtDNA regions were less
represented than others in the sequencing libraries and (2) these
low-abundant sequences are carrying higher methylation levels.
We think that such observation results from the secondary
structure of mtDNA. The mtDNA exists in many topological
structures in the mitochondria: as open circles, supercoiled,
or as catenane circles (linked circles), with the amount of the
different topological structures varying between cell and tissue
types (Pohjoismäki and Goffart, 2011). The compact, secondary
structures of mtDNA are likely to prevent bisulfite conversion,
where unmethylated cytosines can escape deamination and stay
intact. This would result in false positive methylation signal.
In addition, supercoiled structures have been shown to protect
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the DNA from shear forces (Catanese et al., 2012). Thus, the
compact secondary structure of mtDNA may also affect the
ability of certain mtDNA regions to be released by sonication
during the preparation of WMGBS libraries. Together with
blocking access of sodium bisulfite, these structures may decrease
the representation of certain mtDNA sequences and explain
our finding that cytosine conversion rate is associated with
low sequencing coverage. The inverse relationship between
sequencing depth and methylation levels disappeared when
regions were sequenced at a high depth of 250x coverage. To
our knowledge, a relationship between coverage and methylation
levels has not been observed in whole genome bisulfite
sequencing despite the commonly used sequencing coverage of
10x. This reinforces the notion that mtDNA carries specific
properties that justifies adaptation of the bisulfite sequencing
protocol when interrogating mtDNA methylation.
After linearizing mtDNA prior to bisulfite conversion,
cytosine unconversion rate was abolished. Our hypothesis that
the secondary structure of mtDNA leads to bisulfite sequencing
artifact is further supported by the high methylation levels we
detected in undigested samples on a portion of the D-loop (15.1%
for Lonza and 32.3% for SKOV3 cells), where Mitochondrial
Transcription Factor A (TFAM) binds and induces a U-turn
structure (Ngo et al., 2011). When mtDNA was digested prior to
sequencing, methylation at the D-loop region dropped to below
1.5% for both cell lines. These results strongly indicate that the
secondary structure of mtDNA is a source of overestimation
in bisulfite-based mtDNA methylation analysis. Masking of
cytosine by protein-DNA interactions is a cause of bisulfite
sequencing artifact, as showed by lower cytosine conversion
rate in DNA fractions where protein removal is incomplete
(Warnecke et al., 2002). Similarly, the observation that higher
denaturation temperatures lead to higher cytosine conversion
rates indicates that secondary structures may mask cytosine
from bisulfite conversion and lead to an overestimation of
methylation levels (Clark et al., 1994). Recently, it was shown
that methylation levels are found at lower amounts in circular-
compared to linear mtDNA, with methylation levels below
2% in linearized mtDNA (Liu et al., 2016). In the cell types
we used for the currently study, methylation levels observed
after mtDNA digestion were at most 1.5%. The discrepancy
between our results (maximum 1.5%) and the earlier reported
(maximum 2%) (Liu et al., 2016) could be caused by cell-
type specific DNA methylation levels. However, our previous
tests, using spiked-in unmethylated template into the bisulfite
reaction, showed that 1.5% methylation signal corresponds
to background levels in targeted bisulfite sequencing (Barrès
et al., 2009). Thus, this suggests that the level of methylation
detected in the mitochondrial genome corresponds to noise
background. The consistency of very low levels of linearized
mtDNA methylation across different cell types further stresses the
importance of restriction enzyme digestion to avoid secondary
structure-induced overestimation of bisulfite-based detection
of methylation levels. For future studies investigating mtDNA
methylation, BamHI or BglII (Kolesar et al., 2013) may be used
for human and mouse cells, respectively, thereby ensuring an
appropriate estimation of mtDNA methylation.
Change in human mtDNA methylation has been associated
with environmental exposure to pollutants (Janssen et al., 2015;
Zheng et al., 2015) and different disease states (Feng et al.,
2012; Pirola et al., 2013; Baccarelli and Byun, 2015). By targeted
bisulfite sequencing, we detected overall higher methylation
levels in cancer cells as compared to human myotubes when
DNA was not digested prior to bisulfite conversion. However,
after digestion, methylation levels dropped below 1.5% in all cell
lines. Thus, our observation supports that the secondary structure
of mtDNA, rather than absolute cytosine methylation could
be altered by disease state. Further studies, using a systematic
digestion approach prior to bisulfite conversion, are warranted
to conclude on the association between disease and changes in
mtDNA secondary structure.
Using both targeted- and whole genome MeDIP, several
reports have shown an enrichment for both 5 mC and 5 hmC in
the mitochondrial genome (Shock et al., 2011; Bellizzi et al., 2013;
Ghosh et al., 2014, 2016; Jia et al., 2015). Given that methylated
capture-based methods like MeDIP measure exclusively the
relative, and not the absolute level of DNA methylation, their
use for detection of very low levels of methylation may be
disputed. Indeed, methylation enrichment might be technically
biased by capture efficiency at low methylation levels and lack of
appropriate normalizing method or, contamination with NUMTs
in sample. Other non-chemical methods, for instance mass
spectrometry, could in principle be used to quantify mtDNA
methylation however, due to the contamination of nDNA in
mtDNA preparations, quantification by mass spectrometry is
likely to lead to overestimation of mtDNA methylation levels.
The presence of NUMTs in the nuclear genome makes
methylation of certain areas of mtDNA very challenging to assess.
For instance, we identified a large region of the mouse mtDNA
(position 6390–11042) with 100% identity with genomic DNA.
Due to mapping issues, we could not retrieve any methylation
data from that particular mtDNA region. In this study, we
sequenced reads of 300 bp. In humans, none of the 755 known
NUMTs have spans of 300 bp or more with 100% mtDNA
identity (Ramos et al., 2011). Thus, sequencing fragments of
300 bp minimizes greatly the risk of contamination of NUMTs in
WMGBS. For WMGBS, we only used reads mapping uniquely to
the mitochondrial genome and for targeted bisulfite sequencing,
we used Bisearch primer design (Tusnády et al., 2005; Arányi
et al., 2006) and selected only regions that were completely unique
to mtDNA. Designing primers outside NUMTs greatly decreases
the risk of false positives.
CONCLUSION
We identified a likely source of an artifact as a cause for the
overestimation of cytosine methylation in mtDNA and provide
technical insight for bisulfite sequencing of mtDNA. A systematic
use of restriction enzyme digestion prior to bisulfite conversion,
using not only various cell lines, tissues and species but also
various pathological and physiological states, is warranted to
help conclude on the existence of cytosine methylation in
mtDNA.
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